Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FNCH will decline by -4.67% over the next 2 Weeks and hit $12.58 by Wednesday, March 11, 2026. In that time frame, FNCH's share price is expected to range between $12.34 and $12.84.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 11, 2026 | 12.16 | 12.44 | 12.72 |
| Mar 10, 2026 | 12.06 | 12.31 | 12.58 |
| Mar 9, 2026 | 12.29 | 12.55 | 12.82 |
| Mar 6, 2026 | 12.36 | 12.65 | 12.91 |
| Mar 5, 2026 | 12.45 | 12.73 | 12.95 |
| Mar 4, 2026 | 12.43 | 12.67 | 12.93 |
| Mar 3, 2026 | 12.26 | 12.54 | 12.79 |
| Mar 2, 2026 | 12.52 | 12.78 | 13.04 |
| Feb 27, 2026 | 12.64 | 12.88 | 13.13 |
| Feb 26, 2026 | 12.71 | 12.96 | 13.22 |
FNCH shares remained flat 0 in Monday, March 2, 2026's trading session, starting and closing at a previous close of $13.25 to move at $13.25. The stock demonstrated notable intraday movement (see FNCH's key stats for a full breakdown), fluctuating between $13.20 and $13.50, a +2.27% trading range. While recent weeks have seen some volatility, FNCH has managed to secure a -3.64% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 3.26K shares changing hands, 2.68K more than the previous session. This amounted to $43.16K in total market activity.
Will FNCH Continue Its Downward Trend?
According to analyst ratings and projections for FNCH, Finch Therapeutics Group, Inc. shares are anticipated to decrease by -4.19%, potentially reaching $12.72 per share by March 11, 2026. Short-term technical indicators currently suggest a neutral sentiment for FNCH. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the FNCH stock forecast, now is not the best time to buy FNCH stock because its current trading price is +6.50% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on FNCH covering social and institutional perspectives.
FNCH Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FNCH's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.36% to 47.20%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.88%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.54%, maintains a neutral outlook for the long term. Insights into FNCH's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Finch Therapeutics Group Short-Term Forecasts
FNCH Forecast For Next 5 Days
Our algorithm anticipates Finch Therapeutics Group (FNCH) stock could hit $13.29 by Mar 09, 2026. This represents a +0.33% fall from today's price, following a -45.98% change over the past five days.
FNCH Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Finch Therapeutics Group, Inc. (FNCH) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $13.26, which would mean a +0.08% increase from the current price of $13.25. Projections for this period range from a high of $14.03 to a low of $12.44.
FNCH Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Finch Therapeutics Group's price over the next three months point to a rise. FNCH stock is expected to peak at $26.75 on Mar 23, 2026 after potentially dipping to $21.84 on Mar 04, 2026. On average, FNCH is likely to trade around $24.56 in the coming 90 days.
Finch Therapeutics Group Stock Forecast 2025
Based on our predictive models, Finch Therapeutics Group (FNCH) is expected to trade between $9.38 and $31.47 throughout 2026. This would result in an average price of $22.88, potentially offering investors a +72.68% return from current levels.
Finch Therapeutics Group, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Finch Therapeutics Group, Inc. (FNCH) is positioned to show a strong performance in March 2026. The price is predicted to move between $21.84 and $26.75, settling at an average of $24.29. This could translate to a +83.32% gain.
April 2026
Based on current market signals, Finch Therapeutics Group, Inc. is projected to trend april 2026. We forecast a trading range from $22.27 to $26.15, with a likely average price of $24.27. Investors could expect a potential return of +83.17%.
May 2026
Our predictive algorithms indicate Finch Therapeutics Group, Inc. stock may see a shift in May 2026. The expected range spans $23.23–$26.48, with an average target of $25.10. This represents a positive outlook and a possible gain of +89.43%.
June 2026
Analyzing established trends, Finch Therapeutics Group, Inc. looks set to move in June 2026. Projections place the stock between $17.01 and $25.78, averaging around $22.50. This suggests a +69.81% gain from current levels.
July 2026
Market indicators suggest Finch Therapeutics Group, Inc. could experience notable changes during July 2026. Prices could fluctuate within $14.15 to $20.42, with a midpoint forecast of $18.05. The stock might deliver a +36.23% gain.
August 2026
Forecasting for August 2026, models estimate that Finch Therapeutics Group, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $15.33 and $29.78, averaging $23.66. This signals a positive trajectory with potential returns around +78.57%.
September 2026
According to our latest forecast models, Finch Therapeutics Group, Inc. (FNCH) is positioned to show a strong performance in September 2026. The price is predicted to move between $15.89 and $25.97, settling at an average of $22.97. This could translate to a +73.36% gain.
October 2026
Based on current market signals, Finch Therapeutics Group, Inc. is projected to trend october 2026. We forecast a trading range from $15.01 to $31.02, with a likely average price of $24.20. Investors could expect a potential return of +82.64%.
November 2026
Our predictive algorithms indicate Finch Therapeutics Group, Inc. stock may see a shift in November 2026. The expected range spans $13.13–$31.47, with an average target of $24.36. This represents a positive outlook and a possible gain of +83.85%.
December 2026
Analyzing established trends, Finch Therapeutics Group, Inc. looks set to move in December 2026. Projections place the stock between $9.38 and $26.64, averaging around $19.99. This suggests a +50.87% gain from current levels.
January 2027
Market indicators suggest Finch Therapeutics Group, Inc. could experience notable changes during January 2027. Prices could fluctuate within $9.90 to $32.70, with a midpoint forecast of $23.42. The stock might deliver a +76.75% gain.
February 2027
Forecasting for February 2027, models estimate that Finch Therapeutics Group, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $9.87 and $35.18, averaging $24.60. This signals a positive trajectory with potential returns around +85.66%.
FNCH's history of dividends and stock splits also plays a role in long-term investor confidence.

